作者更正：下一代流感疫苗：机遇与挑战。
Author Correction: Next-generation influenza vaccines: opportunities and challenges.
作者信息
Wei Chih-Jen, Crank Michelle C, Shiver John, Graham Barney S, Mascola John R, Nabel Gary J
机构信息
Sanofi Global Research and Development, Cambridge, MA, USA.
Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
出版信息
Nat Rev Drug Discov. 2020 Jun;19(6):427. doi: 10.1038/s41573-020-0066-8.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
本文的一个修订版本已发表，可通过本文顶部的链接获取。
相似文献
1
Author Correction: Next-generation influenza vaccines: opportunities and challenges.作者更正：下一代流感疫苗：机遇与挑战。
Nat Rev Drug Discov. 2020 Jun;19(6):427. doi: 10.1038/s41573-020-0066-8.
2
Author Correction: Ultrasensitive amplicon barcoding for next-generation sequencing facilitating sequence error and amplification-bias correction.作者更正：用于下一代测序的超灵敏扩增子条形码技术，有助于序列错误和扩增偏差校正。
Sci Rep. 2020 Oct 7;10(1):17010. doi: 10.1038/s41598-020-74321-4.
3
Author Correction: Next Generation Sequencing of Pooled Samples: Guideline for Variants' Filtering.作者更正：混合样本的下一代测序：变异筛选指南。
Sci Rep. 2020 Mar 23;10(1):5517. doi: 10.1038/s41598-020-62214-5.
4
Author Correction: Impact of next-generation vehicles on tropospheric ozone estimated by chemical transport model in the Kanto region of Japan.作者更正：通过化学传输模型估算日本关东地区下一代车辆对对流层臭氧的影响。
Sci Rep. 2020 Feb 6;10(1):2382. doi: 10.1038/s41598-020-59300-z.
5
Author Correction: A cross-sectional study to characterize local HIV-1 dynamics in Washington, DC using next-generation sequencing.作者更正：一项使用下一代测序技术来描述华盛顿特区当地HIV-1动态的横断面研究。
Sci Rep. 2020 Apr 22;10(1):7099. doi: 10.1038/s41598-020-63859-y.
6
Author Correction: Identification of Novel Clinically Relevant Variants in 70 Southern Chinese patients with Thoracic Aortic Aneurysm and Dissection by Next-generation Sequencing.作者更正：通过下一代测序技术在70例中国南方胸主动脉瘤和夹层患者中鉴定新型临床相关变异
Sci Rep. 2020 Jun 12;10(1):9856. doi: 10.1038/s41598-020-66839-4.
7
Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8 T-cell response and effective tumor control.作者更正：新一代肿瘤靶向性白细胞介素-2优先促进肿瘤浸润性CD8 T细胞反应及有效的肿瘤控制。
Nat Commun. 2020 Apr 1;11(1):1716. doi: 10.1038/s41467-020-15532-1.
8
Author Correction: Structural restrictions for influenza neuraminidase activity promote adaptation and diversification.作者更正：流感神经氨酸酶活性的结构限制促进适应性和多样化。
Nat Microbiol. 2020 Aug;5(8):1064. doi: 10.1038/s41564-020-0751-8.
9
Author Correction: Highly pathogenic H5N6 avian influenza virus subtype clade 2.3.4.4 indigenous in South Korea.作者更正：韩国本土的高致病性H5N6禽流感病毒2.3.4.4分支亚型
Sci Rep. 2020 Jul 28;10(1):12951. doi: 10.1038/s41598-020-69651-2.
10
Author Correction: Assessing the Dynamics and Control of Droplet- and Aerosol-Transmitted Influenza Using an Indoor Positioning System.作者更正：使用室内定位系统评估飞沫和气溶胶传播的流感的动态和控制。
Sci Rep. 2020 Mar 27;10(1):5792. doi: 10.1038/s41598-020-62682-9.
引用本文的文献
1
A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs.基于猪流感 A（H1N1）病毒血凝素胞外域的铁蛋白纳米疫苗在小鼠和猪中引发了保护性免疫应答。
Front Immunol. 2024 May 21;15:1361323. doi: 10.3389/fimmu.2024.1361323. eCollection 2024.
2
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.基于 ELISA 的检测方法，用于测定源自鸡蛋、细胞或重组蛋白的流感疫苗中的血凝素效力。
Front Immunol. 2023 Mar 22;14:1147028. doi: 10.3389/fimmu.2023.1147028. eCollection 2023.
3
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines.铁蛋白核心中CD4 T细胞表位丰度增强了对血凝素纳米颗粒疫苗的反应。
NPJ Vaccines. 2022 Oct 26;7(1):124. doi: 10.1038/s41541-022-00547-0.
4
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.广谱反应性单域抗体对抗流感病毒及其在疫苗效力测试和免疫治疗中的应用。
Biomolecules. 2021 Mar 10;11(3):407. doi: 10.3390/biom11030407.
Zotero 插件